Contact Us

Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

January

15
2025

Sensus Healthcare Reports First Quarter 2025 Financial Results

21 SRT systems shipped during the quarter; revenues of $8.3…

Read More

January

14
2019

Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radiation Therapy to Treat Non-Melanoma Skin Cancers and Keloids

Published in The Journal of Clinical and Aesthetic Dermatology, Consensus…

Read More

January

14
2019

Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radio Therapy to Treat Non-Melanoma Skin Cancers and Keloids

Published in The Journal of Clinical and Aesthetic Dermatology, Consensus…

Read More

January

13
2019

Modern Medicine – Dr. Brian Berman discusses the problem with keloids.

Researchers found in a retrospective study of 297 surgically excised…

Read More

January

12
2019

Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare’s SRT-100™ for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities

Data from this Non-Invasive, Highly Effective Treatment Option for Non-Melanoma…

Read More
Categories
Categories
Archives
Archives
SRT-100 LOCATOR
Physician Login